Islet inflammation in plain sight

Diabetes, Obesity and Metabolism

Volumn 15, Issue S3, 2013, Pages 105-116

  Abdulreda, M H ^a   Berggren, P O ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anterior chamber; ApoCIII; Diabetes; in vivo imaging; Inflammation; Insulin; Intraocular transplantation; Non invasive; Pancreatic islet; T1D; T2D

Indexed keywords

APOLIPOPROTEIN C3;

ANTERIOR EYE CHAMBER; APOPTOSIS; HUMAN; IMAGING; IMMUNOBIOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOCULAR ISLET TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS SECRETION; PATHOPHYSIOLOGY; REVIEW; TRANSPLANTATION;

ANTERIOR CHAMBER; APOCIII; DIABETES; IN VIVO IMAGING; INFLAMMATION; INSULIN; INTRAOCULAR TRANSPLANTATION; NON-INVASIVE; PANCREATIC ISLET; T1D; T2D;

ANIMALS; CELL TRACKING; DIABETES MELLITUS; DIAGNOSTIC IMAGING; HUMANS; INFLAMMATION; INJECTIONS, INTRAOCULAR; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICROSCOPY, CONFOCAL; PANCREATITIS;

EID: 84883524086     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12160     Document Type: Review

References (75)

1. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105.
2. Timper K, Donath MY. Diabetes mellitus Type 2--the new face of an old lady. Swiss Med Wkly 2012; 142: w13635.
3. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219-226.
4. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
5. Abdulreda MH, Faleo G, Molano RD et al. High-resolution, noninvasive longitudinal live imaging of immune responses. Proc Natl Acad Sci U S A 2011; 108: 12863-12868.
6. Speier S, Nyqvist D, Cabrera O et al. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 2008; 14: 574-578.
7. Speier S, Nyqvist D, Kohler M, Caicedo A, Leibiger IB, Berggren PO. Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 2008; 3: 1278-1286.
8. Wojcikiewicz EP, Abdulreda MH, Zhang X, Moy VT. Force spectroscopy of LFA-1 and its ligands, ICAM-1 and ICAM-2. Biomacromolecules 2006; 7: 3188-3195.
9. Gilbert ER, Liu D. Epigenetics: the missing link to understanding beta-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics 2012; 7: 841-852.
10. Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med 2012; 2: a007724.
11. Eizirik DL, Miani M, Cardozo AK. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 2013; 56: 234-241.
12. Bradley D, Conte C, Mittendorfer B et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest 2012; 122: 4667-4674.
13. Nicol L, Grant WF, Comstock SM et al. Pancreatic inflammation and increased islet macrophages in insulin resistant juvenile primates. J Endocrinol. DOI: 10.1530/joe-12-0424 [Epub 18 February 2013].
14. Galleri L, Sebastiani G, Vendrame F, Grieco FA, Spagnuolo I, Dotta F. Viral infections and diabetes. Adv Exp Med Biol 2012; 771: 252-271.
15. Eizirik DL, Sammeth M, Bouckenooghe T et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012; 8: e1002552.
16. Ehses JA, Perren A, Eppler E et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007; 56: 2356-2370.
17. Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010; 17: 314-321.
18. Mandrup-Poulsen T, Pickersgill L, Donath MY. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol 2010; 6: 158-166.
19. Moore F, Naamane N, Colli ML et al. STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation. J Biol Chem 2011; 286: 929-941.
20. Gurzov EN, Ortis F, Cunha DA et al. Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic beta-cell apoptosis. Cell Death Differ 2009; 16: 1539-1550.
21. Choi HJ, Hwang S, Lee SH et al. Genome-wide identification of palmitate-regulated immediate early genes and target genes in pancreatic beta-cells reveals a central role of NF-κB. Mol Biol Rep 2012; 39: 6781-6789.
22. Barthson J, Germano CM, Moore F et al. Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 2011; 286: 39632-39643.
23. Eldor R, Yeffet A, Baum K et al. Conditional and specific NF-kappaB blockade protects pancreatic β-cells from diabetogenic agents. Proc Natl Acad Sci U S A 2006; 103: 5072-5077.
24. Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009; 32: 1663-1668.
25. Menegazzi M, Novelli M, Beffy P et al. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line. Int J Biochem Cell Biol 2008; 40: 1509-1521.
26. McConathy WJ, Gesquiere JC, Bass H et al. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res 1992; 33: 995-1003.
27. van der Ham RL, Alizadeh Dehnavi R, Berbée JF et al. Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome. Diabetes Care 2009; 32: 184-186.
28. Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 3949-3955.
29. Kawakami A, Aikawa M, Alcaide P et al. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 2006; 114: 681-687.
30. Hokanson JE, Kinney GL, Cheng S et al. Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes. Diabetes 2006; 55: 834-838.
31. van Hoek M, van Herpt TW, Dehghan A et al. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons. Diabetologia 2011; 54: 1360-1367.
32. Eguchi K, Manabe I, Oishi-Tanaka Y et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab 2012; 15: 518-533.
33. Juntti-Berggren L, Refai E, Appelskog I et al. Apolipoprotein CIII promotes Ca2+-dependent β-cell death in type 1 diabetes. Proc Natl Acad Sci U S A 2004; 101: 10090-10094.
34. Yang SN, Berggren PO. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology. Endocr Rev 2006; 27: 621-676.
35. Pollin TI, Damcott CM, Shen H et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008; 322: 1702-1705.
36. Holmberg R, Refai E, Hoog A et al. Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proc Natl Acad Sci U S A 2011; 108: 10685-10689.
37. Storling J, Juntti-Berggren L, Olivecrona G et al. Apolipoprotein CIII reduces proinflammatory cytokine-induced apoptosis in rat pancreatic islets via the Akt prosurvival pathway. Endocrinology 2011; 152: 3040-3048.
38. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol 2004; 15: 239-246.
39. Duivenvoorden I, Teusink B, Rensen PC, Romijn JA, Havekes LM, Voshol PJ. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. Diabetes 2005; 54: 664-671.
40. Kawakami A, Aikawa M, Nitta N et al. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol 2007; 27: 219-225.
41. Xu S, Laccotripe M, Huang X et al. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J Lipid Res 1997; 38: 1289-1298.
42. Shi Y, Yang G, Yu J et al. Apolipoprotein CIII hyperactivates β-cell Cav1 channels by coactivating PKA and Src kinase. 48th EASD Annual Meeting. Berlin, Germany. Diabetologia 2012; 55: S203.
43. Joventino IP, Alves HG, Neves LC et al. The microalga Spirulina platensis presents anti-inflammatory action as well as hypoglycemic and hypolipidemic properties in diabetic rats. J Complement Integr Med 2012; 9: Article 17; DOI: 10.1515/1553-3840.1534.
44. Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV. The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev 2012; 249: 253-275.
45. Coppieters K, Martinic MM, Kiosses WB, Amirian N, von Herrath M. A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy. PLoS One 2010; 5: e15732.
46. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods 2010; 7: 603-614.
47. Cabrera O, Berman DM, Kenyon NS et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006; 103: 2334-2339.
48. Rodriguez-Diaz R, Dando R, Jacques-Silva MC et al. Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming β-cell function in humans. Nat Med 2011; 17: 888-892.
49. Rodriguez-Diaz R, Abdulreda MH, Formoso AL et al. Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 2011; 14: 45-54.
50. Ueda O, Tateishi H, Higuchi Y et al. Novel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptor. Sci Rep 2013; 3: 1196.
51. Holmstock N, Gonzalez FJ, Baes M, Annaert P, Augustijns P. PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein. Mol Pharm 2013; 10: 1056-1062.
52. Leblond F, Davis S, Valdés P, Pogue B. Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications. J Photochem Photobiol B 2010; 98: 77-94.
53. Toso C, Vallee JP, Morel P et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008; 8: 701-706.
54. Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science 1990; 248: 73-76.
55. Cahalan MD, Parker I. Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs. Annu Rev Immunol 2008; 26: 585-626.
56. Speier S, Rupnik M. A novel approach to in situ characterization of pancreatic beta-cells. Pflugers Arch 2003; 446: 553-558.
57. Sabek O, Gaber MW, Wilson CM et al. Imaging of human islet vascularization using a dorsal window model. Transplant Proc 2010; 42: 2112-2114.
58. Bertera S, Geng X, Tawadrous Z et al. Body window-enabled in vivo multicolor imaging of transplanted mouse islets expressing an insulin-Timer fusion protein. Biotechniques 2003; 35: 718-722.
59. Leibiger IB, Caicedo A, Berggren PO. Non-invasive in vivo imaging of pancreatic beta-cell function and survival - a perspective. Acta Physiol (Oxf) 2011; 204: 178-85.
60. Abdulreda MH, Caicedo A, Berggren P-O. Transplantation into the anterior chamber of the eye for longitudinal, non-invasive in vivo imaging with single-cell resolution in real-time. J Vis Exp 2013; 10: e50466.
61. Nyqvist D, Speier S, Rodriguez-Diaz R et al. Donor islet endothelial cells in pancreatic islet revascularization. Diabetes 2011; 60: 2571-2577.
62. Rodriguez-Diaz R, Speier S, Molano RD et al. Noninvasive in vivo model demonstrating the effects of autonomic innervation on pancreatic islet function. Proc Natl Acad Sci U S A 2012; 109: 21456-21461.
63. Dooremaal JC. Die entwickelung der in fremden grund versetzten lebenden gewebe. Albrecht von Graefes Arch Ophthalmol 1873; 19: 359-373.
64. Falck B. Site of production of oestrogen in the ovary of the rat. Nature 1959; 184(Suppl 14): 1082.
65. Niederkorn JY, Larkin DF. Immune privilege of corneal allografts. Ocul Immunol Inflamm 2010; 18: 162-171.
66. Niederkorn JY. High-risk corneal allografts and why they lose their immune privilege. Curr Opin Allergy Clin Immunol 2010; 10: 493-497.
67. Ferguson TA, Apte RS. Angiogenesis in eye disease: immunity gained or immunity lost? Semin Immunopathol 2008; 30: 111-119.
68. Ksander B, Mammolenti M, Streilein J. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function. Transplantation 1991; 52: 128-133.
69. Faleo G, Abdulreda MH, Molano RD et al. Advances in Islet Biology. In: In vivo Non-Invasive Imaging of the Immunopathology of Type 1 Diabetes in NOD Mice. Monterey, California: Keystone Symposium, 2012; 72.
70. Abdulreda MH, Miska J, Devarajan P et al. Cell-cell contact in target tissues and immune damage versus protection. American Diabetes Association 73rd Scientific Sessions. Diabetes 2013; A-2653.
71. Perez VL, Caicedo A, Berman DM et al. The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes. Diabetologia 2011; 54: 1121-1126.
72. Streilein J. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol 1990; 35: 67-73.
73. Adeghate E, Donath T. Morphological findings in long-term pancreatic tissue transplants in the anterior eye chamber of rats. Pancreas 1990; 5: 298-305.
74. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995; 146: 57-79.
75. Abdulreda MH, Molano RD, Molina J et al. In vivo kinetics and dynamics of macrophages in pancreatic islet allografts. American Diabetes Association 70th Scientific Sessions. Orlando, Florida: Diabetes 2010; A360.